Yoga Alongside Standard Buprenorphine Therapy Hastens Opioid Withdrawal Recovery, Improves Autonomic Regulation Compared With Buprenorphine Alone, Trial Shows

MedPage Today (1/7, Firth) reports, “Yoga alongside standard buprenorphine therapy hastened opioid withdrawal recovery and improved autonomic regulation compared with buprenorphine alone, an early-stage randomized trial in India showed.” Researchers found that “among 59 participants with opioid use disorder (OUD) in the intent-to-treat analysis, those in the yoga group recovered from withdrawal faster than those in the control group…with a median stabilization time of 5 days versus 9 days, respectively.” Participants in the yoga group “had better heart rate variability improvements, with large effects on low frequency power, high frequency power, and low frequency/high frequency ratio.” The findings were published in JAMA Psychiatry.

Related Links:

MedPage Today (requires login and subscription)

Switching Therapists, Therapy Approach Offers No Benefits For Patients With MDD Who Do Not Respond To Initial Psychotherapy, Study Finds

HCP Live (1/6, Derman) reports a study found that “changing therapists or therapy approach does not offer additional benefit for adults with major depressive disorder (MDD) who do not respond to initial psychotherapy,” although “further psychotherapy after initial non-response produces modest reductions in depressive symptoms.” The study “showed a modest but statistically significant reduction in depressive symptoms after continuing psychotherapy. However, investigators observed no significant differences in symptom reduction, response, or remission rates between the 3 treatment strategies.” Investigators concluded, “Switching therapist or both therapist and method does not appear to offer additional benefit, but also does not hinder outcomes.” The study was published in the Journal of Affective Disorders.

Related Links:

— “Switching Therapists for Psychotherapy Offers No Advantage in MDD,”Chelsie Derman , HCP Live, January 6, 2026

Pediatric Patients With ADHD More Likely To Receive Negative Parenting, Analysis Suggests

Psychiatric News (1/6) reports a meta-analysis of 62 studies suggests that “children with attention-deficit/hyperactivity disorder (ADHD) are more likely to receive negative parenting – such as lack of warmth or responsiveness to developmental needs, and greater hostility, abuse, or family conflict – than children without the disorder.” Researchers observed that “children with ADHD showed significantly lower levels of positive parenting and higher levels of negative parenting than controls. There were group differences across all 14 parenting factors, but the strongest effects were found for authoritative parenting, warmth, abuse, family conflict, and hostility.” The analysis was published in the Journal of the Academy of Child and Adolescent Psychiatry.

Related Links:

— “Significant Differences Found in Parenting of Children With ADHD, Psychiatric News, January 6, 2026

Stimulants Target Brain’s Reward And Wakefulness Centers, But Not Attention Networks, Study Shows

The Washington Post (1/6, Johnson) reports a new study shows that “the stimulants Ritalin and Adderall…don’t act on the brain’s attention circuitry as had long been assumed.” Rather, the ADHD medications “primarily target the brain’s reward and wakefulness centers.” The research team “compared images of children who took prescription stimulants on the day of their scan with those of children who did not take stimulants. By studying the connections that allow different regions of the brain to communicate with one another, the scientists discovered that stimulants were promoting increased activity in the wakefulness and reward regions, but not in the attention ones.” The study “supports an increasing body of research that has pointed toward lack of proper sleep as a contributor to ADHD.” The study was published in Cell.

Related Links:

— “The Washington Post (requires login and subscription)

AMA urges Congress to make Medicare telehealth changes permanent before waiver expires

HIT Consultant (1/5, Pennic) reports, “The AMA is urging Congress to pass permanent authorization of Medicare telehealth services before the current waiver expires on January 30, 2026.” According to HIT Consultant, “This advocacy follows a ‘tumultuous’ 2025 in which a 43-day government shutdown caused a 24% national drop in fee-for-service telemedicine visits, demonstrating the extreme sensitivity of patient access to legislative lapses.” In a recent statement, AMA President Bobby Mukkamala, MD, said, “Since the COVID-19 public health emergency, Congress has repeatedly extended telehealth flexibilities for Medicare patients-often at the last moment-creating uncertainty for millions of patients and their physicians.” Dr. Mukkamala added, “As the current waiver deadline approaches, Congress must finally act decisively to prevent a disruptive and abrupt halt to the expanded telehealth services that have improved care continuity, chronic disease management, and access for rural and underserved communities.”

Related Links:

— “AMA’s Strategic Push for Permanent Medicare Telehealth Reform,”Fred Pennic , HIT Consultant, January 5, 2026

State Bans On Flavored E-Cigarettes Reduced Vaping Initiation For Young Adults, Study Finds

Psychiatric News (1/5) reports a study found that “young people living in one of four states with flavoring bans for e-cigarettes were only half as likely as peers in other states without such bans to start vaping.” The research team “analyzed responses to the Population Assessment of Tobacco and Health (PATH) Study from four states that implemented sales bans for all flavored e-cigarettes – Maryland, Massachusetts, New Jersey, and New York – and compared them to 36 states without bans.” They observed that “among young adults (ages 18 to 24), e-cigarette flavor bans were associated with a more than 50% decrease in starting vaping from the pre-ban rate (6.05 percentage point decrease in initiation). However, no significant change was observed among adolescents (ages 12 to 17) or adults age ≥25 years.” Furthermore, they noted “flavor bans didn’t reduce initiation among disadvantaged subpopulations.” The study was published in JAMA Network Open.

Related Links:

— “States Banning Flavored E-Cigarettes Reduced Initiation by Young Adults, Psychiatric News , January 5, 2026

US Teens Spend 70 Minutes Of School Days On Their Phones, Study Finds

CNN (1/5, Alaimo) reports a study found that American 13- to 18-year-olds “spend an average of 70 minutes of their school days on their phones.” Prior research “shows that’s merely one slice of the 8 ½ hours teens spend daily on screen-based entertainment.” According to the study, “the teens spent most of their phone time during the school day on social media apps such as TikTok, Instagram and Snapchat,” and they “spent an average of nearly 15 minutes of each school day on gaming apps and almost 15 minutes on video apps such as YouTube.” More schools are enacting policies to restrict phone use, but “the study suggested teens are finding ways to evade the rules.” Notably, the “study only tracked Android users, so it’s possible iPhone users have different phone use habits.” The study was discussed in a JAMA research letter.

Related Links:

— “Kids are spending a lot of their school days on their phones,”Kara Alaimo, CNN, January 5, 2026

Nearly 40% Of Americans Will Make A Mental Health Resolution For 2026, Poll Shows

Psychiatric News (1/2) reported the APA’s latest Healthy Minds Poll shows that “38% of adults say they plan to make a mental health-related New Year’s resolution, up 5% from the previous year’s survey.” Overall, 82% of respondents “planned to make at least one New Year’s resolution for 2026. Resolutions centered on physical fitness (44%), financial goals (42%), and mental health (38%) were the top areas of focus. Younger adults ages 18 to 34 (58%) and 35 to 44 (51%) were much more likely to plan a mental health resolution than adults 45 to 64 (32%) and 65+ (11%).” Additionally, “22% of U.S. adults rated their mental health as excellent in 2025, while 41% rated it as good, 28% as fair, and 8% as poor.”

Related Links:

— “Nearly 4 in 10 Americans Will Plan a Mental Health Resolution for 2026, Psychiatric News , January 2, 2026

Adding Daily Fish Oil Supplement To Psychotherapy Shows No Significant Benefit In Pediatric Patients With Major Depressive Disorder, Study Finds

MedPage Today (1/2, Monaco) reported a study found that “adding a daily fish oil supplement to psychotherapy showed no significant benefit over placebo for kids and teens with moderate-to-severe major depressive disorder (MDD).” The researchers observed that “average Children’s Depression Rating Scale-Revised (CDRS-R) scores similarly improved by week 36 among youth who underwent standardized psychotherapy with an omega-3 fatty acid supplement or with placebo.” Furthermore, “depression remission (CDRS-R score ≤28 points) actually occurred more often by week 36 with placebo than with the omega-3 supplement (31.9% vs 41.1%), as did the proportion meeting response criteria (31.2% vs 39.1% with ≥30% reduction in CDRS-R scores) by week 12.” The study was published in JAMA Network Open.

Related Links:

MedPage Today (requires login and subscription)

Congress Approves Spending Package With Funding For Mental Health Agencies, Behavioral Health Investments

Psychiatric News (2/4) reports Congress on Tuesday passed “a $1.2 trillion spending package for fiscal year 2026 that maintained or increased funding for several key mental health agencies, including the National Institute of Mental Health (NIMH) and the Substance Abuse and Mental Health Services Administration (SAMHSA).” The legislation funds most of the federal government through September 30 and “includes authorization and funding for several of APA’s advocacy priorities, including telehealth flexibilities, supporting health equity, and more.” Notably, the package extends “telehealth flexibilities – including waiving the requirement for Medicare patients to have an in-person visit within the past six months to begin” telehealth – for nearly two years, through December 31, 2027.

Related Links:

— “Congress Passes Spending Package With Behavioral Health Investments, Psychiatric News , February 4, 2026